PETRINI, IACOPO
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 118
AS - Asia 46
AF - Africa 6
SA - Sud America 3
Totale 731
Nazione #
US - Stati Uniti d'America 551
IT - Italia 68
DE - Germania 17
VN - Vietnam 14
SG - Singapore 9
CN - Cina 8
UA - Ucraina 8
IN - India 7
ZA - Sudafrica 5
AT - Austria 4
HN - Honduras 4
CA - Canada 3
CL - Cile 3
FR - Francia 3
GB - Regno Unito 3
SE - Svezia 3
HK - Hong Kong 2
NL - Olanda 2
RS - Serbia 2
RU - Federazione Russa 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
TR - Turchia 1
Totale 731
Città #
Fairfield 57
Santa Cruz 48
Seattle 45
Ashburn 40
Buffalo 35
Woodbridge 33
Houston 29
Serra 27
Wilmington 22
Cambridge 14
Chicago 14
Dong Ket 10
Las Vegas 10
Des Moines 9
Phoenix 9
Redmond 9
Ann Arbor 8
Florence 8
Rome 8
Henderson 5
Riva 5
Beijing 4
Bengaluru 4
Clearwater 4
Milan 4
San Diego 4
Vienna 4
Dallas 3
Fleming Island 3
Los Angeles 3
San Francisco 3
Shanghai 3
Stockholm 3
University Park 3
Belgrade 2
Centro 2
Frankfurt Am Main 2
Johannesburg 2
London 2
Mountain View 2
Muizenberg 2
New York 2
Ottawa 2
Pisa 2
Provo 2
Tappahannock 2
Vedano Olona 2
Atlanta 1
Auburn 1
Bari 1
Bhubaneswar 1
Bissen 1
Blacksburg 1
Bremen 1
Brierley Hill 1
Büdelsdorf 1
Cairo 1
Capannori 1
Crugers 1
Delhi 1
Dubai 1
Edison 1
Fort Wayne 1
Forte dei Marmi 1
Gyor 1
Herndon 1
Istanbul 1
Kowloon 1
Lake Forest 1
Lehavim 1
Levico Terme 1
Lombard 1
Lugo 1
Miami 1
Milpitas 1
Pacific 1
Palo Alto 1
Paravola 1
Paris 1
Parlin 1
Portland 1
Potenza 1
Potsdam 1
Providence 1
Riga 1
Rochester 1
San Pedro Sula 1
Scranton 1
Silverton 1
Sofiyevskaya Borshchagovka 1
Tegucigalpa 1
Toronto 1
Yellow Springs 1
Totale 562
Nome #
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA, file e0d6c929-f65c-fcf8-e053-d805fe0aa794 112
null, file e0d6c928-8a94-fcf8-e053-d805fe0aa794 104
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup, file e0d6c92c-7650-fcf8-e053-d805fe0aa794 102
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology, file e0d6c92a-ddff-fcf8-e053-d805fe0aa794 93
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment, file e0d6c92a-0b5b-fcf8-e053-d805fe0aa794 91
Implications of KRAS mutations in acquired resistance to treatment in NSCLC, file e0d6c929-b8bf-fcf8-e053-d805fe0aa794 75
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA, file e0d6c927-4b88-fcf8-e053-d805fe0aa794 67
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia, file e0d6c92c-8d1b-fcf8-e053-d805fe0aa794 36
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results, file e0d6c931-65e4-fcf8-e053-d805fe0aa794 22
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME), file e0d6c931-352f-fcf8-e053-d805fe0aa794 12
Nanotopography Induced Human Bone Marrow Mesangiogenic Progenitor Cells (MPCs) to Mesenchymal Stromal Cells (MSCs) Transition, file e0d6c92c-1f09-fcf8-e053-d805fe0aa794 10
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC, file e0d6c92f-d61a-fcf8-e053-d805fe0aa794 9
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer, file e0d6c931-86aa-fcf8-e053-d805fe0aa794 5
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms, file e0d6c92b-6a5f-fcf8-e053-d805fe0aa794 4
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation, file 491c47e5-9e0b-4d01-bd94-f2ab61d4d8ea 3
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer., file e0d6c92a-000b-fcf8-e053-d805fe0aa794 3
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report, file e0d6c92d-2e09-fcf8-e053-d805fe0aa794 3
Recent advances in epigenomics in NSCLC: Real-time detection and therapeutic implications, file e0d6c928-24f7-fcf8-e053-d805fe0aa794 2
ErbB in NSCLC as a molecular target: Current evidences and future directions, file e0d6c92f-3a19-fcf8-e053-d805fe0aa794 2
Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow, file e0d6c930-fd7a-fcf8-e053-d805fe0aa794 2
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM), file e0d6c931-73d6-fcf8-e053-d805fe0aa794 2
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: A retrospective review of 22 patients, file e0d6c931-d803-fcf8-e053-d805fe0aa794 2
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment, file e0d6c929-e088-fcf8-e053-d805fe0aa794 1
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance, file e0d6c92a-ac58-fcf8-e053-d805fe0aa794 1
GTF2I mutations are common in thymic epithelial tumors but not in hematological malignancies, file e0d6c92c-7657-fcf8-e053-d805fe0aa794 1
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES), file e0d6c92c-8ef9-fcf8-e053-d805fe0aa794 1
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA, file e0d6c92e-2b61-fcf8-e053-d805fe0aa794 1
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation, file e0d6c931-88d5-fcf8-e053-d805fe0aa794 1
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients, file e0d6c931-8f17-fcf8-e053-d805fe0aa794 1
Totale 768
Categoria #
all - tutte 1.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 5 0 0 1 1 3 7 8 10
2019/2020184 3 7 4 7 29 21 19 31 25 10 14 14
2020/2021116 7 10 13 6 10 5 8 12 9 9 11 16
2021/2022164 12 5 5 10 18 8 10 5 13 3 55 20
2022/2023201 3 7 51 27 17 21 9 15 6 16 22 7
2023/202445 13 13 19 0 0 0 0 0 0 0 0 0
Totale 768